These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10593115)

  • 1. [Hepatotoxicity of cyclosporine in patients with kidney transplants].
    Karamehić J; Ascerić M; Tulumović T; Kabil E; Uzeirbegović M; Hadzibegić N
    Med Arh; 1999; 53(4):193-5. PubMed ID: 10593115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue therapy with tacrolimus in renal graft patients with cyclosporine A-induced hepatotoxicity: a preliminary study.
    Yuan QS; Zheng FL; Sun Y; Yu Y; Li Y
    Transplant Proc; 2000 Nov; 32(7):1694-5. PubMed ID: 11119896
    [No Abstract]   [Full Text] [Related]  

  • 3. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
    Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
    Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine.
    Hecking M; Kainz A; Schillinger M; Posch C; Birsan T; Rasoul-Rockenschaub S; Böhmig GA; Schmaldienst S; Watschinger B; Hörl WH; Mühlbacher F; Säemann MD
    Transpl Int; 2008 Mar; 21(3):223-33. PubMed ID: 17903183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity associated with cyclosporine monitoring using C2 recommendations in adults renal recipients receiving ketoconazole.
    Videla C; Vega J; Borja H
    Transplant Proc; 2005 Apr; 37(3):1574-6. PubMed ID: 15866677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity and liver enzyme alteration in patients with immunobullous diseases receiving immunosuppressive therapy.
    Shahshahani MM; Azizahari S; Soori T; Manavi S; Balighi K; Daneshpazhooh M; Davatchi CS; Esmaili N
    J Dermatol; 2011 Dec; 38(12):1153-7. PubMed ID: 21981904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of liver disease in kidney transplant recipients on cyclosporine dose and metabolite levels.
    Alfurayh O; Sobh M; Minhas M; Almeshari K; Alshaibani K; Qunibi W; Aesha H; Taher S
    Transplant Proc; 1994 Oct; 26(5):2655. PubMed ID: 7940830
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal function outcome in pediatric liver transplant recipients.
    Mention K; Lahoche-Manucci A; Bonnevalle M; Pruvot FR; Declerck N; Foulard M; Gottrand F
    Pediatr Transplant; 2005 Apr; 9(2):201-7. PubMed ID: 15787794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patients.
    Li J; Dahmen U; Beckebaum S; Cicinnati V; Valentin-Gamazo C; Frilling A; Malago M; Broelsch CE
    Eur J Med Res; 2006 Apr; 11(4):139-45. PubMed ID: 16720277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy.
    Hesselink DA; van Dam T; Metselaar HJ; Balk AH; Mathôt RA; Smak Gregoor PJ; Weimar W; van Gelder T
    Transpl Int; 2004 Oct; 17(9):495-504. PubMed ID: 15338117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple organ failure in a kidney transplant patient receiving both colchicine and cyclosporine.
    Minetti EE; Minetti L
    J Nephrol; 2003; 16(3):421-5. PubMed ID: 12832745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty liver and transaminase changes with adjuvant tamoxifen therapy.
    Liu CL; Huang JK; Cheng SP; Chang YC; Lee JJ; Liu TP
    Anticancer Drugs; 2006 Jul; 17(6):709-13. PubMed ID: 16917217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C2 therapeutic drug monitoring of cyclosporine is a safe and feasible method in de novo heart transplant patients.
    Puehler T; Goepel L; v Tschirschnitz M; Struckmeyer U; Ernst M; Ladenburger S; Schmid C; Cremer J; Hirt SW
    Transplant Proc; 2007 Dec; 39(10):3329-33. PubMed ID: 18089381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of sirolimus and cyclosporine does not delay initial renal graft function recovery.
    Hsu HJ; Tian YC; Chen YC; Lai BC; Fang JT; Yang CW; Wu MS
    Ren Fail; 2008; 30(3):303-6. PubMed ID: 18350450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effects of anisodamine for CyA hepatotoxicity in the rat and in renal-transplant recipients.
    Wang X; Tang X; Xie T; Sun X
    Transplant Proc; 1997; 29(1-2):286-7. PubMed ID: 9122998
    [No Abstract]   [Full Text] [Related]  

  • 16. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients.
    Langers P; Cremers SC; den Hartigh J; Veenendaal RA; ten Hove WR; Ringers J; Lamers CB; van Hoek B
    Liver Transpl; 2004 Feb; 10(2):183-9. PubMed ID: 14762854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
    Tumgor G; Arikan C; Kilic M; Aydogdu S
    Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of cyclosporine and its metabolites in blood via HPLC-MS and correlation to clinically important parameters.
    Vollenbroeker B; Koch JH; Fobker M; Suwelack B; Hohage H; Müller U
    Transplant Proc; 2005 May; 37(4):1741-4. PubMed ID: 15919451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.